Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Oncorus, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 50 | 48 | −2 |
| Shares | 20.5M | 19.9M | −558.5K (−2.7%) |
| Value | $282.6M | $186.2M | −$96.4M (−34.1%) |
New holders (5)
Institutions that held Oncorus, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 192,054 | $1.79M | 0.48% |
| Mirae Asset Global Investments Co., Ltd. | 145,020 | $1.35M | 0.00% |
| Two Sigma Investments, LP | 30,753 | $287.0K | 0.00% |
| Renaissance Technologies LLC | 30,071 | $281.0K | 0.00% |
| Millennium Management LLC | 23,134 | $216.0K | 0.00% |
Sold out (7)
Institutions that held Oncorus, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 77,148 | $1.06M |
| Maven Securities LTD | 64,838 | $950.0K |
| UBS Group AG | 60,940 | $841.0K |
| Virtu Financial LLC | 14,006 | $193.0K |
| Manufacturers Life Insurance Company, The | 12,473 | $172.0K |
| Wells Fargo & Company | 198 | $3.00K |
| Parallel Advisors, LLC | 59 | $1.00K |